Form 4: Kymera Therapeutics Director Acquires Stock Options

Director Bruce Booth acquired stock options for 16,000 shares of Kymera Therapeutics common stock on June 18, 2024.

Summary

• On June 18, 2024, Bruce Booth, a director of Kymera Therapeutics, Inc. (KYMR), acquired stock options for 16,000 shares of the company's common stock.
• The exercise price of the options is $31.20 per share.
• The options vest fully on the earlier of June 18, 2025, or the date of the next annual meeting of the Issuer's stockholders.
• The options expire on June 17, 2034.
• Booth disclaims ownership of the securities, as the proceeds from any sale will be transferred to Atlas Venture Life Science Advisors, LLC, except to the extent of his pecuniary interest.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing related to stock option grants, which is neither particularly positive nor negative. It's a neutral disclosure of information.

Industry Context

This filing is a routine disclosure of stock option grants to a company director, which is a common practice in publicly traded companies to incentivize and align the interests of directors with those of shareholders.

Comparison to Industry Standards

• Stock option grants to directors are a standard practice in the biotechnology industry.
• Companies like Amgen, Gilead Sciences, and Vertex Pharmaceuticals also grant stock options to their directors as part of their compensation packages.
• The vesting schedule and exercise price are typical for such grants, aligning with industry norms for incentivizing long-term performance.

Related Party Transactions

• The proceeds of any sale of shares of common stock issued to the Reporting Person upon exercise of this option will be transferred to Atlas Venture Life Science Advisors, LLC.

Stakeholder Impact

• The stock option grant aligns the director's interests with those of the shareholders, incentivizing him to work towards increasing the company's value.
• The grant has no immediate impact on employees, customers, suppliers, or creditors.

Key Dates